Céline Tiffon obtained her PhD in Tumor Biology from the University of Bern, Switzerland, working on the subject of liver and pancreatic cancers. She carried out postdoctoral research at the Cancer Science Division of the University of Southampton, United Kingdom. Her research interests focused on the molecular mechanisms triggered by two licensed HDAC inhibitors in cutaneous T-cell lymphoma with a particular emphasis on cytokine expression. She continued with postdoctoral research at the University of Burgundy, France, working on the topic of endocrine disruptors. She currently works as a scientific officer at the National Cancer Institute, France.